Skip to main content
. 2021 Apr 16;24(2):123–137. doi: 10.4048/jbc.2021.24.e22

Table 3. Molecular subtypes of newly diagnosed breast cancers in 2018 in Korea (KBCS registry data).

Molecular subtype No. of patients
HR (+), HER2 (−) 6.226 (68.4)
HR (+), HER2 (+) 1.035 (11.4)
HR (−), HER2 (−) 838 (9.2)
HR (−), HER2 (−) 997 (11.0)
Total 9.096 (100.0)

Values are presented as number (%).

KBCS = Korean Breast Cancer Society; HR = hormone receptor; HER2 = human epidermal growth factor receptor-2.